Balchem Debt to Equity Ratio 2010-2025 | BCPC
Current and historical debt to equity ratio values for Balchem (BCPC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Balchem debt/equity for the three months ending March 31, 2025 was 0.18.
| Balchem Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2025-03-31 |
$0.41B |
$1.21B |
0.34 |
| 2024-12-31 |
$0.43B |
$1.15B |
0.37 |
| 2024-09-30 |
$0.42B |
$1.18B |
0.36 |
| 2024-06-30 |
$0.46B |
$1.11B |
0.42 |
| 2024-03-31 |
$0.51B |
$1.08B |
0.47 |
| 2023-12-31 |
$0.54B |
$1.05B |
0.52 |
| 2023-09-30 |
$0.58B |
$1.03B |
0.56 |
| 2023-06-30 |
$0.61B |
$1.01B |
0.61 |
| 2023-03-31 |
$0.66B |
$0.97B |
0.67 |
| 2022-12-31 |
$0.69B |
$0.94B |
0.73 |
| 2022-09-30 |
$0.74B |
$0.90B |
0.82 |
| 2022-06-30 |
$0.71B |
$0.90B |
0.78 |
| 2022-03-31 |
$0.32B |
$0.87B |
0.37 |
| 2021-12-31 |
$0.32B |
$0.88B |
0.37 |
| 2021-09-30 |
$0.29B |
$0.89B |
0.33 |
| 2021-06-30 |
$0.30B |
$0.87B |
0.35 |
| 2021-03-31 |
$0.32B |
$0.85B |
0.38 |
| 2020-12-31 |
$0.34B |
$0.83B |
0.41 |
| 2020-09-30 |
$0.34B |
$0.82B |
0.42 |
| 2020-06-30 |
$0.36B |
$0.79B |
0.45 |
| 2020-03-31 |
$0.40B |
$0.77B |
0.52 |
| 2019-12-31 |
$0.41B |
$0.74B |
0.55 |
| 2019-09-30 |
$0.36B |
$0.73B |
0.50 |
| 2019-06-30 |
$0.37B |
$0.73B |
0.50 |
| 2019-03-31 |
$0.26B |
$0.71B |
0.37 |
| 2018-12-31 |
$0.29B |
$0.69B |
0.42 |
| 2018-09-30 |
$0.30B |
$0.69B |
0.44 |
| 2018-06-30 |
$0.33B |
$0.66B |
0.49 |
| 2018-03-31 |
$0.33B |
$0.64B |
0.51 |
| 2017-12-31 |
$0.35B |
$0.62B |
0.56 |
| 2017-09-30 |
$0.37B |
$0.59B |
0.64 |
| 2017-06-30 |
$0.41B |
$0.56B |
0.73 |
| 2017-03-31 |
$0.40B |
$0.54B |
0.74 |
| 2016-12-31 |
$0.43B |
$0.52B |
0.82 |
| 2016-09-30 |
$0.43B |
$0.52B |
0.83 |
| 2016-06-30 |
$0.46B |
$0.50B |
0.92 |
| 2016-03-31 |
$0.49B |
$0.48B |
1.02 |
| 2015-12-31 |
$0.42B |
$0.46B |
0.90 |
| 2015-09-30 |
$0.43B |
$0.46B |
0.93 |
| 2015-06-30 |
$0.43B |
$0.44B |
0.98 |
| 2015-03-31 |
$0.44B |
$0.41B |
1.08 |
| 2014-12-31 |
$0.47B |
$0.39B |
1.20 |
| 2014-09-30 |
$0.47B |
$0.38B |
1.25 |
| 2014-06-30 |
$0.54B |
$0.36B |
1.51 |
| 2014-03-31 |
$0.04B |
$0.34B |
0.11 |
| 2013-12-31 |
$0.05B |
$0.33B |
0.14 |
| 2013-09-30 |
$0.04B |
$0.32B |
0.11 |
| 2013-06-30 |
$0.03B |
$0.31B |
0.11 |
| 2013-03-31 |
$0.04B |
$0.29B |
0.12 |
| 2012-12-31 |
$0.04B |
$0.27B |
0.15 |
| 2012-09-30 |
$0.04B |
$0.27B |
0.14 |
| 2012-06-30 |
$0.04B |
$0.25B |
0.15 |
| 2012-03-31 |
$0.04B |
$0.24B |
0.14 |
| 2011-12-31 |
$0.04B |
$0.23B |
0.17 |
| 2011-09-30 |
$0.04B |
$0.22B |
0.16 |
| 2011-06-30 |
$0.04B |
$0.21B |
0.18 |
| 2011-03-31 |
$0.04B |
$0.20B |
0.20 |
| 2010-12-31 |
$0.04B |
$0.19B |
0.22 |
| 2010-09-30 |
$0.04B |
$0.18B |
0.19 |
| 2010-06-30 |
$0.04B |
$0.17B |
0.21 |
| 2010-03-31 |
$0.04B |
$0.16B |
0.25 |
| 2009-12-31 |
$0.04B |
$0.15B |
0.28 |
| 2009-09-30 |
$0.04B |
$0.14B |
0.26 |
| 2009-06-30 |
$0.04B |
$0.13B |
0.26 |
| 2009-03-31 |
$0.04B |
$0.12B |
0.30 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$5.560B |
$0.954B |
|
Balchem Corporation provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. Balchem Company consists of four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications.
|
